Advertisement

Human Physiology

, Volume 38, Issue 5, pp 522–527 | Cite as

Combination of two danger signals (microorganisms and xenobiotics) is the principal cause of activation of chronic inflammatory processes

  • K. A. Lebedev
Article
  • 56 Downloads

Abstract

Chronic inflammatory diseases are of long duration, during which remissions alternate with exacerbations. Until recently, it was believed that the occurrence and activation of a chronic inflammatory process is caused by one danger signal, usually by microorganisms. Taken together, our own and the published data show that the activation of an inflammatory process is associated with the accumulation of macrophages in an inflammatory focus and their subsequent hyperactivation as a result of the combination of two danger signals—microorganisms and xenobiotics.

Keywords

chronic inflammation microorganisms xenobiotics macrophages M1 and M2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Garcia, R. and Dietrich, T., Introduction to Periodontal Epidemiology, Periodontology, 2000, vol. 58, p. 7.CrossRefGoogle Scholar
  2. 2.
    Academy Report “Epidemiology of Periodontal Diseases,” J. Periodontol., 2005, vol. 76, no. 8, p. 1406.Google Scholar
  3. 3.
    Dedova, L.N., Kandrukevich, O.V., and Bondarik, E.A., The State of Periodontal Tissue and Root Surface Caries According to the Epidemiological Survey 35 to 54 Year Old Residents of the Republic of Belarus, Stomatol. Zh., 2006, no. 4, p. 322.Google Scholar
  4. 4.
    Kuzmina, E.M, Kuzmina, I.N., Petrina, S.E., et al., Stomatologicheskaya zabolevaemost’ naseleniya Rossii. Sostoyanie tkanei parodonta i slizistoi obolochki rta (Dental Morbidity in Russia. The State of Periodontal Tissues and Oral Mucosa), Yanushevich, O.O., Ed., Moscow: MGMSU, 2009.Google Scholar
  5. 5.
    Shaju, J.P., Zade, R.M., and Das, M., Prevalence of Periodontitis in the Indian Population, J. Indian Soc. Periodontol., 2011, vol. 15, no. 1, p. 29.PubMedCrossRefGoogle Scholar
  6. 6.
    Cosnes, J., Gower-Rousseau, C., Seksik, P., and Cortot, A., Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, 2011, vol. 140, no. 6, p. 1785.PubMedCrossRefGoogle Scholar
  7. 7.
    Lebedev, K.A. and Ponyakina, I.D., The Focus of Pathological (Toxic) Action of Metals in the Human Body and the Role of Galvanic Currents in Its Formation, Hum. Physiol., 2011, vol. 37, no. 4, p. 471.CrossRefGoogle Scholar
  8. 8.
    Lebedev, K.A. and Ponyakina, I.D., Immunologiya obrazraspoznayushchikh retseptorov (Immunology of Pattern Recognition Receptors), Moscow: URSS, 2009.Google Scholar
  9. 9.
    Bejarano, E. and Cuervo, A.M., Chaperone-Mediated Autophagy, Proc. Am. Thorac. Soc., 2010, vol. 7, no. 1, p. 29.PubMedCrossRefGoogle Scholar
  10. 10.
    Orenstein, S.J. and Cuervo, A.M., Chaperone-Mediated Autophagy. Molecular Mechanisms and Physiological Relevance, Semin. Cell Dev. Biol., 2010, vol. 21, no. 7, p. 719.PubMedCrossRefGoogle Scholar
  11. 11.
    Mosser, D.M., The Many Faces of Macrophage Activation, J. Leukocyte Biol., 2003, vol. 73, p. 209.PubMedCrossRefGoogle Scholar
  12. 12.
    Gordon, S. and Martinez, F.O., Alternative Activation of Macrophages: Mechanism and Functions, Immunity, 2010, vol. 32, p. 593.PubMedCrossRefGoogle Scholar
  13. 13.
    Laskin, D.L., Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces, Chem. Res. Toxicol., 2009, vol. 22, no. 8, p. 1376.PubMedCrossRefGoogle Scholar
  14. 14.
    Lebedev, K.A. and Ponyakina, I.D., Physiological Mechanisms of Inflammation and Atopic Allergy, Hum. Physiol., 2000, vol. 26, no. 6, p. 722.CrossRefGoogle Scholar
  15. 15.
    Lebedev, K.A., Ponyakina, I.D., and Kozachenko, N.V., Physiology of Chronic Inflammatory Processes and Their Treatment, Hum. Physiol., 2005, vol. 31, no. 1, p. 86.CrossRefGoogle Scholar
  16. 16.
    Lebedev, K.A. and Ponyakina, I.D., Impairment of the Tolerance of an Organism to Its Own Microflora Is a Kind of Immune Pathology, Hum. Physiol., 2003, vol. 29, no. 2, p. 259.CrossRefGoogle Scholar
  17. 17.
    Lebedev, K.A. and Ponyakina, I.D., The Role of Heat Shock Proteins in the Formation of Conflict between the Human Body and Its Microflora, Hum. Physiol., 2007, vol. 33, no. 3, p. 342.CrossRefGoogle Scholar
  18. 18.
    Lebedev, K.A. and Ponyakina, I.D., Immunophysiological Mechanisms of the Origin and Maintenance of Tumor Growth in Humans, Hum. Physiol., 2010, vol. 36, no. 4, p. 373.CrossRefGoogle Scholar
  19. 19.
    Lebedev, K.A., Doinikov, A.I., Ponyakina, I.D., et al., The Role of the Presence of Chronic Inflammatory Diseases in the Development of Multiple Allergy Intolerance to Prosthetic Material, Stomatologiya, 2006, no. 3, p. 19.Google Scholar
  20. 20.
    Lebedev, K.A., Mitronin, A.V., and Ponyakina, I.D., Neperenosimost’ zuboproteznykh materialov (Intolerance of Dental Materials), Moscow: URSS, 2010.Google Scholar
  21. 21.
    Tabas, I., Macrophage Death and Defective Inflammation Resolution in Atherosclerosis, Nat. Rev. Immunol., 2010, vol. 10, no. 1, p. 36.PubMedGoogle Scholar
  22. 22.
    James, G.A., Swogger, I.A., Wolcott, E.R., et al., Biofilms in Chronic Wounds, Wound Repair Regen., 2008, vol. 16, no. 1, p. 37.PubMedCrossRefGoogle Scholar
  23. 23.
    Rudney, J.D., Chen, R., and Sedgewick, G.J., Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis Are Components of a Polymicrobial Intracellular Flora within Human Buccal Cells, J. Dent. Res., 2005, vol. 84, no. 1, p. 59.PubMedCrossRefGoogle Scholar
  24. 24.
    Garlet, G.P., Destructive and Protective Roles of Cytokines in Periodontitis: A Reappraisal from Host Defense and Tissue Destruction Viewpoints, J. Dent. Res., 2010, vol. 89, no. 12, p. 1349.PubMedCrossRefGoogle Scholar
  25. 25.
    Graves, D., Cytokines That Promote Periodontal Tissue Destruction, J. Periodontol., 2008, vol. 79, no. 8, p. 1585.PubMedCrossRefGoogle Scholar
  26. 26.
    Benoit, M., Desnues, B., and Mege, J.-L., Macrophage Polarization in Bacterial Infections, J. Immunol., 2008, vol. 181, p. 3733.PubMedGoogle Scholar
  27. 27.
    Ricardo, S.D., van Goor, H., and Eddy, A.A., Macrophage Diversity in Renal Injury and Repair, J. Clin. Invest., 2008, vol. 118, no. 11, p. 3522.PubMedCrossRefGoogle Scholar
  28. 28.
    Graves, D.T., Li, J., and Cochran, D.L., Inflammation and Uncoupling As Mechanisms of Periodontal Bone Loss, J. Dent. Res., 2011, vol. 90, no. 2, p. 143.PubMedCrossRefGoogle Scholar
  29. 29.
    Devlin, R.D., Reddy, S.V., Savino, R., et al., IL-6 Mediates the Effects of IL-1 or TNF, but not PTHrP or 1.25(OH)2D3, on Osteoclast-Like Cell Formation in Normal Human Bone Marrow Cultures, J. Bone Miner. Res., 1998, vol. 13, p. 393.PubMedCrossRefGoogle Scholar
  30. 30.
    Frost, A., Jonsson, K.B., Nilsson, O., and Ljunggren, O., Inflammatory Cytokines Regulate Proliferation of Cultured Human Osteoblasts, Acta Orthop. Scand., 1997, vol. 68, p. 91.PubMedCrossRefGoogle Scholar
  31. 31.
    Ketlinskii, S.A. and Simbirtsev, A.S., Tsitokiny (Cytokines), St. Petersburg: Foliant, 2008.Google Scholar
  32. 32.
    Laskin, D.L., Sunil, V.R., Gardner, C.R., and Laskin, J.D., Macrophages and Tissue Injury: Agents of Defense or Destruction?, Ann. Rev. Pharmacol. Toxicol., 2011, vol. 51, p. 267.CrossRefGoogle Scholar
  33. 33.
    Laskin, D.L., Nonparenchymal Cells and Hepatotoxicity, Semin. Liver Dis., 1990, vol. 10, p. 293.PubMedCrossRefGoogle Scholar
  34. 34.
    Laskin, D.L. and Pendino, K.J., Macrophages and Inflammatory Mediators in Tissue Injury, Ann. Rev. Pharmacol. Toxicol., 1995, vol. 35, p. 655.CrossRefGoogle Scholar
  35. 35.
    Lloyd, S.A. and Franklin, M.R., Modulation of Carbon Tetrachloride Hepatotoxicity and Xenobiotic-Metabolizing Enzymes by Corticosterone Pretreatment, Adrenalectomy and Sham Surgery, Toxicol. Lett., 1991, vol. 55, p. 65.PubMedCrossRefGoogle Scholar
  36. 36.
    Madhu, C. and Klaassen, C.D., Protective Effect of Pregnenolone-16 alpha-Carbonitrile on Acetaminophen Induced Hepatotoxicity in Hamsters, Toxicol. Appl. Pharmacol., 1991, vol. 109, p. 305.PubMedCrossRefGoogle Scholar
  37. 37.
    Madhu, C., Maziasz, T., and Klaassen, C.D., Effect of Pregnenolone-16 alpha-Carbonitrile and Dexamethasone on Acetaminophen-Induced Hepatotoxicity in Mice, Toxicol. Appl. Pharmacol., 1992, vol. 115, p. 191.PubMedCrossRefGoogle Scholar
  38. 38.
    Sudhir, S. and Budhiraja, R.D., Comparison of the Protective Effect of Withaferin-“A” and Hydrocortisoneagainst CCl4 Induced Hepatotoxicity in Rats, Indian J. Physiol. Pharmacol., 1992, vol. 36, p. 127.PubMedGoogle Scholar
  39. 39.
    Ju, C., Reilly, T.P., Bourdi, M., et al., Protective Role of Kupffer Cells in Acetaminophen-Induced Hepatic Injury in Mice, Chem. Res. Toxicol., 2002, vol. 15, p. 1504.PubMedCrossRefGoogle Scholar
  40. 40.
    Ito, Y., Bethea, N.W., Abril, E.R., and McCuskey, R.S., Early Hepatic Microvascular Injury in Response to Acetaminophen Toxicity, Microcirculation, 2003, vol. 10, p. 391.PubMedGoogle Scholar
  41. 41.
    Muriel, P. and Escobar, Y., Kupffer Cells Are Responsible for Liver Cirrhosis Induced by Carbon Tetrachloride, J. Appl. Toxicol., 2003, vol. 23, p. 103.PubMedCrossRefGoogle Scholar
  42. 42.
    Abdel-Zaher, A.O., Abdel-Rahman, M.M., Hafez, M.M., and Omran, F.M., Role of Nitric Oxide and Reduced Glutathione in the Protective Effects of Aminoguanidine, Gadolinium Chloride and Oleanolic Acid against Acetaminophen-Induced Hepatic and Renal Damage, Toxicology, 2007, vol. 234, p. 124.PubMedCrossRefGoogle Scholar
  43. 43.
    Cheng, L., You, Q., Yin, H., et al., Effect of PolyI:C Cotreatment on Halothane Induced Liver Injury in Mice, Hepatology, 2009, vol. 9, p. 215.CrossRefGoogle Scholar
  44. 44.
    Dejager, L. and Libert, C., Tumor Necrosis Factor alpha Mediates the Lethal Hepatotoxic Effects of Poly(I:C)in D-Galactosamine-Sensitized Mice, Cytokine, 2008, vol. 42, p. 55.PubMedCrossRefGoogle Scholar
  45. 45.
    Galanos, C., Freudenberg, M.A., and Reutter, W., Galactosamine-Induced Sensitization to the Lethal Effects of Endotoxin, Proc. Natl. Acad. Sci. USA, 1979, vol. 76, p. 5939.PubMedCrossRefGoogle Scholar
  46. 46.
    Ganey, P.E., Luyendyk, J.P., Maddox, J.F., and Roth, R.A., Adverse Hepatic Drug Reactions: Inflammatory Episodes as Consequence and Contributor, Chem. Biol. Interact., 2004, vol. 150, p. 35.PubMedCrossRefGoogle Scholar
  47. 47.
    Duffield, S., The Inflammatory Macrophage: A Story of Jekyll and Hyde, Clin. Sci., 2003, vol. 104, p. 27.PubMedCrossRefGoogle Scholar
  48. 48.
    Moldoveanu, B., Otmishi, P., Jani, P., et al., Inflammatory Mechanisms in the Lung, J. Inflamm. Res., 2009, vol. 2, p. 1.PubMedGoogle Scholar
  49. 49.
    Varin, A., Mukhopadhyay, S., Herbein, G., and Gordon, S., Alternative Activation of Macrophages by IL-4 Impairs Phagocytosis of Pathogens but Potentiates Microbial-Induced Signalling and Cytokine Secretion, Blood, 2010, vol. 115, no. 2, p. 353.PubMedCrossRefGoogle Scholar
  50. 50.
    Khallou-Laschet, J., Varthaman, A., Fornasaet, G., et al., Macrophage Plasticity in Experimental Atherosclerosis, PloS, 2010, vol. 5, no. 1, p. 8852.CrossRefGoogle Scholar
  51. 51.
    Hudspith, B.N. and Elliott, T., Defective Macrophage Function in Crohn’s Disease: Role of Alternatively Activated Macrophages in Inflammation, Gut, 2011, vol. 60, p. 143.Google Scholar
  52. 52.
    Lebedev, K.A., Maksimovskii, Yu.M., and Sagan, N.N., Principles of Determination of Galvanic Currents in the Oral Cavity and Their Clinical Substantiation, Stomatologiya, 2007, no. 4, p. 11.Google Scholar
  53. 53.
    Ponyakina, I.D., Mitronin, A.V., Sagan, N.N., and Sagan, L.G., Identification of Electric Currents That Determine Pathological Galvanic Syndrome in the Oral Cavity, Endotol. Today, 2007, no. 1, p. 34.Google Scholar
  54. 54.
    Kuryakina, N.V. and Kutepova, T.F., Zabolevaniya parodonta (Periodontal Diseases), Moscow: Meditsinskaya kniga, 2003.Google Scholar
  55. 55.
    Deng, X., Luyendyk, J.P., Ganey, P.E., and Roth, R.A., Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models, Pharmacol. Rev., 2009, vol. 61, no. 3, p. 262.PubMedCrossRefGoogle Scholar
  56. 56.
    Lebedev, K.A. and Ponyakina, I.D., Immunnaya nedostatochnost’ (vyyavlenie i lechenie) (Immune Deficiency (Identification and Treatment)), Moscow: Meditsinskaya kniga, 2003.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2012

Authors and Affiliations

  • K. A. Lebedev
    • 1
  1. 1.Clinical Diagnostic CenterMoscow State Medical Stomatological UniversityMoscowRussia

Personalised recommendations